FDA Approved: DEFINITY — Supplemental Application (Lantheus Medical Imaging, Inc.)

View source ↗

Summary

FDA approved a supplemental application for DEFINITY (perflutren lipid microsphere) from Lantheus Medical Imaging, Inc., to update labeling for its use as an ul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• DEFINITY (perflutren lipid microspheres)

Snippet

SUPPL AP for DEFINITY (PERFLUTREN)